Group 1 had a higher proportion of male patients and a lower proportion of diabetes mellitus (DM), myocardial infarction (MI), or congestive heart failure (CHF), and administered renin–angiotensin system blockers, aspirin, or clopidogrel than those in the other groups. This evidence concerns the gene REN and myocardial infarction.